Canada markets close in 4 hours 5 minutes

BeiGene, Ltd. (BGNE)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
194.77-16.38 (-7.76%)
As of 11:52AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous Close211.15
Open199.00
Bid194.60 x 100
Ask195.71 x 100
Day's Range194.11 - 200.75
52 Week Range126.97 - 215.00
Volume319,127
Avg. Volume274,212
Market Cap21.09B
Beta (5Y Monthly)0.61
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
All
News
  • Business Wire

    BeiGene Announces Updates to Commercial Leadership Team

    SAN MATEO, Calif., September 09, 2024--BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, today announced the appointment of Matt Shaulis as General Manager of North America, effective September 25.

  • Business Wire

    BeiGene Highlights TEVIMBRA® Data in Lung and Gastrointestinal Cancers at ESMO 2024

    BASEL, Switzerland, September 09, 2024--BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, today announced it will share new data for TEVIMBRA® (tislelizumab) at the European Society of Medical Oncology 2024 Congress (ESMO 2024) in Barcelona, Spain, September 13-17, 2024. BeiGene has seven abstracts accepted at ESMO 2024, with one selected for the special session revisiting the ESMO Virtual Plenary held in February 2024.

  • Business Wire

    BeiGene to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference

    SAN MATEO, Calif., August 28, 2024--BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, today announced it will participate in the Morgan Stanley 22nd Annual Global Healthcare Conference on September 5, 2024, with a fireside chat at 10 a.m. EDT.